Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
104.20    -0.60 (-0.57%)
Bid:
103.60
Ask:
105.40
Spread: 1.80 (1.737%)
Market Cap: £438.01m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Update

15 Jun 2017 07:00

RNS Number : 1190I
PZ CUSSONS PLC
15 June 2017
 

15 June 2017

PZ Cussons Plc

(the "Group")

 

TRADING UPDATE

 

PZ Cussons Plc, a leading international consumer products group, today issues the following trading update in respect of the year ended 31 May 2017.

Overview

 

The board is pleased to announce that the overall performance of the Group has been in line with expectations.

 

The Group's balance sheet remains strong with cash generation for the period also in line with expectations.

 

Europe

 

In the UK, performance in the washing and bathing division has been robust with renovation and innovation continuing to drive good performance across Imperial Leather, Carex and Original Source despite competitive market conditions. The Imperial Leather range has been completely relaunched during the year and successful product launches have taken place under the Carex and Original Source brands.

 

In the beauty division, Sanctuary, St Tropez, Charles Worthington and Fudge have all performed well. The relaunch of the Sanctuary brand has now been completed with a new product range and a more premium look and feel. The new sub-brand, Being by Sanctuary, is now available in store and online and is targeting younger consumers with a range of 46 products. New product launches under the St Tropez brand include a new-to-market self-tan face mask.

 

Performance in the smaller markets of Poland and Greece has been in line with expectations.

 

Asia

 

In Australia, new product launches, range extensions and margin improvement initiatives have continued to improve the profitability of the business despite ongoing challenging trading conditions and all brands are performing well.

 

In Indonesia, good growth has continued across the brand portfolio with Cussons Baby strengthening its market leading position. Successful product launches in the year include the relaunch of the Cussons Kids range together with a new range of Imperial Leather products.

 

Performance in the smaller markets of Thailand and the Middle East has been in line with expectations.

 

Africa

 

In Nigeria, whilst liquidity has improved during the second half, availability of US dollars at the interbank rate remains low resulting in the need to continue accessing the secondary market.

 

All business units across Personal Care, Home Care, Electricals and Food & Nutrition have continued to trade relatively well in an environment where the consumer is under significant inflationary pressure. The Group's diverse product range with product offerings at all price points has ensured that market shares are held or grown across the brand portfolio.

 

Performance in the smaller markets of Ghana and Kenya has been in line with expectations.

 

Outlook

 

The strength and agility of the Group's brand portfolio is underpinning solid performance in all regions and new product launches are performing well.

 

Tight control of costs together with further margin improvement initiatives are successfully countering ongoing raw material and exchange rate volatility.

 

The Group's balance sheet remains strong and well placed to pursue new opportunities as they arise.

 

Final Results

 

Final results for the year ended 31 May 2017 will be announced on Tuesday 25 July 2017.

 

- ENDS -

For further information contact:

 

PZ Cussons Plc

Brandon Leigh - Chief Financial Officer

 

Tel: 0161 435 1236

Instinctif

Tim Linacre / Guy Scarborough

Tel: 020 7457 2020

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUQGQUPMGQC
Date   Source Headline
4th Jul 20237:00 amRNSCapital Markets Event
30th Jun 20232:18 pmRNSDirector/PDMR Shareholding
29th Jun 202311:06 amRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSTrading Statement
21st Jun 20239:59 amRNSDirector/PDMR Shareholding
16th Jun 20237:00 amRNSDirectorate Change
19th May 20239:27 amRNSDirector/PDMR Shareholding
21st Apr 20239:00 amRNSIntention to Conduct Audit Tender
19th Apr 202310:01 amRNSDirector/PDMR Shareholding
13th Apr 20233:18 pmRNSHolding(s) in Company
13th Apr 20237:00 amRNSQ3 Trading Update
12th Apr 20232:18 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSDirectorate Change
21st Mar 20239:30 amRNSDirector/PDMR Shareholding
17th Mar 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20239:31 amRNSDirector/PDMR Shareholding
8th Feb 20237:00 amRNS2023 Interim Results
19th Jan 20234:20 pmRNSDirector/PDMR Shareholding
20th Dec 20222:40 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:55 pmRNSDirector/PDMR Shareholding
24th Nov 20223:24 pmRNSResult of AGM
24th Nov 20227:00 amRNSDirectorate Change
21st Nov 20223:21 pmRNSDirector/PDMR Shareholding
14th Nov 20227:00 amRNSNew Credit Facility Linked to B Corp Ambitions
18th Oct 20223:52 pmRNSDirector/PDMR Shareholding
14th Oct 20227:00 amRNSPublication of Annual Report and Notice of AGM
27th Sep 202210:52 amRNSDirector/PDMR Shareholding
23rd Sep 20223:04 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNS2022 Full Year Results
21st Sep 202210:06 amRNSDirector Declaration
2nd Sep 202210:29 amRNSHolding(s) in Company
19th Aug 202210:05 amRNSDirector/PDMR Shareholding
29th Jul 20229:46 amRNSDirector/PDMR Shareholding
20th Jul 20223:21 pmRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSTrading update
21st Jun 20224:10 pmRNSDirector/PDMR Shareholding
20th May 202210:30 amRNSFurther re 2021 AGM voting results
19th May 20225:45 pmRNSDirector/PDMR Shareholding
21st Apr 202210:30 amRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSTrading Statement
1st Apr 20229:00 amRNSDirector/PDMR Shareholding
25th Mar 202210:00 amRNSDirector/PDMR Shareholding
23rd Mar 20229:00 amRNSDirector/PDMR Shareholding
21st Mar 202210:15 amRNSDirector/PDMR Shareholding
21st Mar 20227:00 amRNSAcquisition of Childs Farm
21st Feb 202211:00 amRNSDirector/PDMR Shareholding
11th Feb 20229:25 amRNSDirector/PDMR Shareholding
11th Feb 20229:15 amRNSBoard update
9th Feb 20227:00 amRNSHalf-year Report
19th Jan 202210:10 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.